The Patent Finder

Terms ending in 2034

Amgen Inc.

Every in-force patent on Amgen Inc.'s record whose computed term ends in 2034, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 10,314,976Method of Assembling and Filling a Drug Delivery Device
In force
 · Low confidence
Amgen Inc.In forceLow confidence
US 11,129,941Method of Assembling and Filling a Drug Delivery Device
In force
 · High confidence
Amgen Inc.In forceHigh confidence
US 11,135,356Controlled Delivery Drive Mechanisms For Drug Delivery Pumps
In force
 · Medium confidence
Amgen Inc.In forceMedium confidence
US D838,359On-Body Injector
In force
 · High confidence
Amgen Inc.In forceHigh confidence
US 10,955,291Methods of Determining Exposure to Uv Light
In force
 · High confidence
Amgen Inc.In forceHigh confidence
US 9,920,121Antibodies Targeting CDH19 for Melanoma
In force
 · Medium confidence
Amgen Inc.In forceMedium confidence
US 10,059,766Antibody Constructs for CDH19 and CD3
In force
 · High confidence
Amgen Inc.In forceHigh confidence
US 11,053,311Antibodies Targeting CDH19 for Melanoma
In force
 · Medium confidence
Amgen Inc.In forceMedium confidence
US 9,309,263Fused Multi-Cyclic Sulfone Compounds as Inhibitors of Beta-Secretase and Methods of Use Thereof
In force
 · High confidence
Amgen Inc.In forceHigh confidence
US 9,814,832Drive Mechanism for Drug Delivery Pumps with Integrated Status Indication
In force
 · High confidence
Amgen Inc.In forceHigh confidence
123 more term ends in 2034 · Pro
10 of 133 patents shown. Soonest term end first, then patent number.
Pro members see all 133.
Upgrade to Pro
123 of these are in force and held by Amgen Inc..
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited